Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Teva
Novartis
Johnson and Johnson
McKesson
Julphar
Daiichi Sankyo
Colorcon
Moodys
Federal Trade Commission

Generated: January 16, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,215,113

« Back to Dashboard

Summary for Patent: 4,215,113
Title: Method for combating virus infections
Abstract:A method for the selective treatment of virus infections in animals and man, comprising administering to a host so infected a therapeutically effective amount of phosphonoformic acid or a physiologically acceptable salt thereof.
Inventor(s): Eriksson; Bertil F. H. (Sodertalje, SE), Helgstrand; Ake J. E. (Enhorna, SE), Misiorny; Alfons (Bandhagen, SE), Stening; Goran B. (Sodertalje, SE), Stridh; Stig-Ake A. (Sodertalje, SE)
Assignee: Astra Lakemedel Aktiebolag (Sodertalje, SE)
Application Number:05/807,783
Patent Claims: 1. A method for the selective treatment of virus infections in an animal or human host comprising administering to said host so infected an amount effective to treat said virus infection of phosphonoformic acid or a physiologically acceptable salt thereof.

2. A method according to claim 1 for the treatment of infections caused by herpes viruses.

3. A method according to claim 1 for the treatment of infections caused by herpes simplex type 1 viruses.

4. A method according to claim 1 for the treatment of infections caused by herpes simplex type 2 viruses.

5. A method according to claim 1 for the treatment of infections caused by varicella (Herpes zoster) viruses.

6. A method according to claim 1 for the treatment of infections caused by cytomegalo viruses.

7. A method according to claim 1 for the treatment of infections caused by Epstein-Barr viruses.

8. A method according to claim 1 for the treatment of infections caused by influenza viruses.

9. A method according to claim 1 for the treatment of infections caused by influenza type A or B viruses.

10. A method according to claim 1 for the treatment of infections caused by influenza type A viruses.

11. A method according to claim 1 for the treatment of infections, caused by papilloma viruses.

12. A method according to claim 1 for the treatment of herpes dermatitis, herpes genitalis, herpes keratitis and herpes encephalitis.

13. A method according to claim 1 for the treatment of herpes zoster.

14. A method according to claim 1 for the treatment of infectious mononucleosis.

15. A method according to claim 1 for the treatment of influenza.

16. A method according to claim 1 for the treatment of warts.

17. A method according claim 1, comprising topical administration of phosphonoformic acid or a physiologically acceptable salt thereof.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Accenture
Fuji
Harvard Business School
Teva
Deloitte
Cerilliant
McKinsey
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot